The application of this engager resulted in in vitro and ex vivo augmented activation of patient PBMC NK cells and lysis of EGFR-expressing tumor cell lines and metastatic colorectal patient-derived cancer cells [57]. The gene discussed is EGFR; the disease is neoplasm.